Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Atnt
AddedFeb 18, 2024
UpdatedJun 18, 2026
Atnt

Atnt

ATNT: Pioneering protein discovery with patented tech, offering unique services to pharma and biotech firms.

HQ
Newark, NJ, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

ATNT, short for Advanced Technologies for Novel Therapeutics, is a biotech company dedicated to pioneering protein discovery using patented technologies. The company offers unique services to pharmaceutical and biotech firms, focusing on identifying the most important therapeutic targets in complex cellular networks. Founded by well-recognized university professors with expertise in molecular biology, cell biology, biochemistry, and related fields, ATNT leverages cross-disciplinary engineering methods to develop novel tools and techniques for treating complex human disorders.

ATNT has achieved significant recognition, including the President & CEO being selected to receive the New Jersey Inventors Hall of Fame Award. This accolade highlights the company's innovative contributions to biotechnology. With a team of high-profile experts in engineering and biology, ATNT continues to impact the pharmaceutical and biotech industries by providing advanced solutions for therapeutic target identification.

Atnt - Similar Companies

Novatarg logo

Novatarg

novatarg.org

Atavistik Bio logo

Atavistik Bio

atavistikbio.com

Atterx BioTherapeutics logo

Atterx BioTherapeutics

atterx.com

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Novel Therapeutic Technologies logo

Novel Therapeutic Technologies

ntt-inc.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Atalanta Therapeutics logo

Atalanta Therapeutics

atalantatx.com

Novopyxis logo

Novopyxis

novopyxis.com

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

Antheia logo

Antheia

antheia.bio

Alltrna logo

Alltrna

alltrna.com

Initial Therapeutics logo

Initial Therapeutics

initialtx.com

Antek logo

Antek

antekinc.com

Entact Bio logo

Entact Bio

entactbio.com

EpiBiologics logo

EpiBiologics

epibiologics.com

Atnt - Quick Facts

Who are Atnt's competitors?

Companies similar to Atnt include Novatarg, Atavistik Bio, Atterx BioTherapeutics and Adcentrx Therapeutics.

When was Atnt founded?

Atnt was founded in 2008.

Where is Atnt's headquarters located?

Atnt's headquarters is located in Newark, NJ, US.

When was Atnt's last funding round?

Atnt's most recent funding round was for $150k (USD) in December 2012.

How much has Atnt raised to-date?

As of Dec 11, 2012, Atnt has raised a total of $150k (USD).

How many employees does Atnt have?

Atnt has 7 employees as of Feb 4, 2024.

Atnt - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • API
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software